相关实验视频

Updated: Jun 4, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

用ECT治疗的忧郁和未指定的抑郁症患者中的MADRS单项差异变化:一项探索性研究

Beatriz Pozuelo Moyano¹, Setareh Ranjbar², Kevin Swierkosz-Lenart¹

¹Service of Old Age Psychiatry, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.

Frontiers in psychiatry

|December 19, 2024

概括

患有忧郁性重度抑郁症 (M-MDD) 的患者在电治疗 (ECT) 后在MADRS尺度上表现出较大的改善,相比未指定的MDD (U-MDD). 这表明M-MDD可能对ECT有更好的反应,特别是在特定的症状集群中.

科学领域:

精神病学是一个精神病学.
神经科学是一个神经科学.
临床心理学临床心理学

背景情况:

重度抑郁症 (MDD) 是一种异质的疾病,对治疗的反应有变化.
电疗法 (ECT) 是严重MDD的有效治疗方法,但反应模式在亚型之间可能有所不同.
了解特定亚型对ECT的反应对于个性化治疗策略至关重要.

研究的目的:

在ECT后,研究忧郁型MDD (M-MDD) 和未指定的MDD (U-MDD) 之间的蒙哥马利-阿斯伯格抑郁评分表 (MADRS) 单个项目中的差异变化.
探索特定的抑郁症状是否在M-MDD和U-MDD中在ECT后有不同的改善.

主要方法:

对23名单极性MDD患者的探索性分析,这些患者接受了ECT治疗.
根据DSM-5标准,患者被分为M-MDD或U-MDD.
在基线和ECT后一个月评估MADRS得分,并进行统计分析,包括Wilcoxon测试和多重线性回归.

主要成果:

M-MDD组 (10名患者) 的MADRS得分比U-MDD组 (13名患者) 的基线得分更高,除了报告的悲伤,自杀念头和注意力集中障碍.
在ECT后的M-MDD组中,总MADRS得分的降低明显更大.
在对共变量进行调整后,M-MDD患者的特定症状改善 (明显的悲伤,无法感觉,悲观的想法,睡眠障碍,食欲下降,注意力集中障碍) 更明显.

结论:

在ECT后一个月,M-MDD比U-MDD的MADRS得分降低更为显著,无论是总得分还是特定项目.
这些发现表明,在忧郁和未指定的抑郁亚型之间,对ECT的反应可能有所差异.
需要进行更大的样本研究来证实在MDD亚型的ECT后MADRS反应中观察到的这些差异.

关键词:

美国美国 ECT ECT ECT ECT 母亲们的母亲们大型抑郁症主要是抑郁症.忧郁的抑郁症忧郁的抑郁症不明确的抑郁症不明确的抑郁

更多相关视频

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil

Published on: October 4, 2016

相关概念视频

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...